| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |